Melbas personal page - To The Moon

Melbas

Melbas

No personal profile

14Follow

3Followers

0Topic

0Badge

2023-06-18

Gg yg. B. Ta.\_[\.[ B f C

3 Top Stocks to Buy and Hold for the Next Decade

2023-05-18

$Ault Alliance, Inc.(AULT)$ Are they real??? 😳😳😳😳

2022-04-08

$Clever Leaves Holdings Inc.(CLVR)$Uhhhh noo

2022-03-28

$Clever Leaves Holdings Inc.(CLVR)$Keep or Sale???

2022-03-27

$Clever Leaves Holdings Inc.(CLVR)$Up

2022-03-26

$Clever Leaves Holdings Inc.(CLVR)$I know it 🤣

2022-03-25

$Sundial Growers Inc.(SNDL)$Yay happy

2022-03-19

B b but yh by n but,1bwrd oac kc pMmm Hi go back

@咏竹坊:Securities Regulator Takes on VIEs. Now It Needs to Address DRs

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4110356800596672","uuid":"4110356800596672","gmtCreate":1647253731038,"gmtModify":1648383174208,"name":"Melbas","pinyin":"melbas","introduction":"","introductionEn":null,"signature":"","avatar":"https://community-static.tradeup.com/news/4e59f56cdf45369101c12b25d1af19af","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":14,"tweetSize":8,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.27","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.27","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.27","exceedPercentage":"60.40%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":188607563837472,"gmtCreate":1687072468129,"gmtModify":1687072472770,"author":{"id":"4110356800596672","authorId":"4110356800596672","name":"Melbas","avatar":"https://community-static.tradeup.com/news/4e59f56cdf45369101c12b25d1af19af","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4110356800596672","idStr":"4110356800596672"},"themes":[],"htmlText":"Gg yg. &nbsp;B. Ta.\\_[\\.[ B f C","listText":"Gg yg. &nbsp;B. Ta.\\_[\\.[ B f C","text":"Gg yg. B. Ta.\\_[\\.[ B f C","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/188607563837472","repostId":"2343196599","repostType":2,"repost":{"id":"2343196599","pubTimestamp":1687053533,"share":"https://ttm.financial/m/news/2343196599?lang=&edition=fundamental","pubTime":"2023-06-18 09:58","market":"us","language":"en","title":"3 Top Stocks to Buy and Hold for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2343196599","media":"Motley Fool","summary":"These stalwarts can form the foundation of your portfolio.","content":"<html><head></head><body><p>A decade is a long time. But it&#39;s not impossible to identify the companies best situated to grow their revenue and earnings at above-average rates over the next 10 years. It can be a worthwhile and highly profitable exercise, as the companies stand to deliver fortune-building gains.</p><p>Here are three outstanding businesses that just might fit the bill. All three are set to benefit from powerful trends in the coming decade and deliver handsome rewards to their shareowners.</p><h2>1. <a href=\"https://laohu8.com/S/BEP\">Brookfield Renewable Partners</a></h2><p>With climate change concerns mounting, the shift toward cleaner energy is set to be one of the most important and lucrative trends of the coming decade. <strong>Brookfield Renewable Partners</strong> (BEP) is exceptionally well-positioned to profit from this global megatrend.</p><p>Brookfield Renewable is built to help the world achieve its energy transition and decarbonization goals. It owns a diverse collection of high-quality assets spanning wind, solar, hydroelectric, and other sustainable power projects. Its businesses are also geographically diversified, with operations across five continents. </p><p>The limited partnership is designed to pass its bountiful cash flow on to its investors via a steadily growing distribution, which currently yields over 4%.  With demand for clean energy assured, Brookfield Renewable believes its investment pipeline will enable it to grow its already hefty cash payout by 5% to 9% annually and deliver total returns to investors of 12% to 15% per year. </p><h2>2. <a href=\"https://laohu8.com/S/LLY\">Eli Lilly</a></h2><p>With potential blockbuster drugs in three massive markets -- diabetes, obesity, and Alzheimer&#39;s -- <strong>Eli Lilly</strong> (LLY) has an unrivaled growth pipeline among the pharmaceutical giants. Moreover, health trends suggest that the need for safe and effective treatments for these medical conditions will continue to grow as more people are expected to suffer from these disorders in the decade ahead. </p><p>Lilly&#39;s Mounjaro received Food and Drug Administration (FDA) approval in May 2022 as an injectable medicine for adults with type 2 diabetes, to be used along with diet and exercise to improve glycemic control.</p><p>Better still, the drug (also known as tirzepatide) produced promising results in a phase 3 clinical trial for weight loss. Participants in the 72-week study lost as much as 34 pounds, with more than 80% of people achieving at least a 5% reduction in body weight. Tirzepatide has multibillion-dollar sales potential in an obesity drug market that could reach $200 billion in the coming decade, according to investment bank <strong>Barclays</strong>. </p><p>Lilly has another potential blockbuster in donanemab. In a phase 3 trial, it slowed cognitive and functional decline in patients with early Alzheimer&#39;s disease by 35% compared to a placebo.  Donanemab also helped to clear brain plaque that is associated with the disease, which affects more than 6 million in the U.S. alone. </p><p>Lilly&#39;s well-stocked drug portfolio should allow it to generate impressive sales and profit growth -- and, by extension, strong returns to shareholders -- in the years ahead.</p><h2>3. <a href=\"https://laohu8.com/S/TSLA\">Tesla</a></h2><p><strong>Tesla</strong> (TSLA) is another exceptional business that&#39;s poised to benefit from multiple megatrends. The first, of course, is the shift from gasoline-powered cars and trucks to electric vehicles (EVs). As the industry leader, it stands to profit from the rapidly rising adoption of battery-powered vehicles more than any other company.</p><p>Profitability is improving as it scales up its production. The automaker&#39;s high operating margins are enabling it to reduce the prices of its vehicles to boost sales. This should help Tesla progress toward its goal of producing 20 million EVs per year by 2030, up from less than 1.4 million in 2022. </p><p>An intensifying focus on software could drive profit margins even higher in the coming years. Cathy Wood&#39;s Ark Investment Management believes advances in autonomous driving technology will create an $11 trillion market opportunity by the end of the decade. Tesla is investing aggressively in self-driving tech and is well-positioned to be a leader in this potentially enormous industry. </p><p>It also stands to benefit from the automation trend. The company unveiled its humanoid robot concept, called Optimus, at its AI Day event in September. It intends to develop and eventually mass-produce an AI-powered robot that can take on &#34;dangerous, repetitive, and boring tasks,&#34; according to CEO Elon Musk.</p><p>The project is a priority for Musk, who believes Optimus could become the most valuable portion of the business in time. With such intriguing growth opportunities in EVs, self-driving software, and robotics, Tesla gives its shareholders many ways to win.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Top Stocks to Buy and Hold for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Top Stocks to Buy and Hold for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-06-18 09:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/06/16/3-top-stocks-to-buy-and-hold-for-the-next-decade/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A decade is a long time. But it's not impossible to identify the companies best situated to grow their revenue and earnings at above-average rates over the next 10 years. It can be a worthwhile and ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/06/16/3-top-stocks-to-buy-and-hold-for-the-next-decade/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LU0056508442.USD":"贝莱德世界科技基金A2","LU0719512351.SGD":"JPMorgan Funds - US Technology A (acc) SGD","BK4551":"寇图资本持仓","BK4574":"无人驾驶","IE00B1XK9C88.USD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A\" (USD) ACC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","BK4581":"高盛持仓","LU2249611893.SGD":"BNP PARIBAS ENERGY TRANSITION \"CRH\" (SGD) ACC","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","LU0234572021.USD":"高盛美国核心股票组合Acc","BK4099":"汽车制造商","BK4511":"特斯拉概念","LU2063271972.USD":"富兰克林创新领域基金","BK4548":"巴美列捷福持仓","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","IE00BWXC8680.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5\" (SGD) ACC","LU0823414478.USD":"法巴经典能源转换基金","LU0097036916.USD":"贝莱德美国增长A2 USD","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","LU2087621335.USD":"ALLSPRING GLOBAL FACTOR ENHANCED EQUITY \"A\" (USD) ACC","LU2326559502.SGD":"Natixis Loomis Sayles US Growth Equity P/A SGD-H","LU1852331112.SGD":"Blackrock World Technology Fund A2 SGD-H","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","LU1861215975.USD":"贝莱德新一代科技基金 A2","TSLA":"特斯拉","LU0316494557.USD":"FRANKLIN GLOBAL FUNDAMENTAL STRATEGIES \"A\" ACC","LU1861558580.USD":"日兴方舟颠覆性创新基金B","LU1548497426.USD":"安联环球人工智能AT Acc","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","BK4533":"AQR资本管理(全球第二大对冲基金)","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","BK4555":"新能源车","LU0348723411.USD":"ALLIANZ GLOBAL HI-TECH GROWTH \"A\" (USD) INC","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","BK4527":"明星科技股","LU1429558221.USD":"Natixis Loomis Sayles US Growth Equity RA USD","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU1839511570.USD":"WELLS FARGO GLOBAL FACTOR ENHANCED EQUITY \"I\" (USD) ACC","BK4550":"红杉资本持仓","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4588":"碎股","LU0053666078.USD":"摩根大通基金-美国股票A（离岸）美元","LU1435385759.SGD":"Natixis Loomis Sayles US Growth Equity RA SGD-H","LU0823411888.USD":"法巴消费创新基金 Cap","LU0082616367.USD":"摩根大通美国科技A（dist）"},"source_url":"https://www.fool.com/investing/2023/06/16/3-top-stocks-to-buy-and-hold-for-the-next-decade/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2343196599","content_text":"A decade is a long time. But it's not impossible to identify the companies best situated to grow their revenue and earnings at above-average rates over the next 10 years. It can be a worthwhile and highly profitable exercise, as the companies stand to deliver fortune-building gains.Here are three outstanding businesses that just might fit the bill. All three are set to benefit from powerful trends in the coming decade and deliver handsome rewards to their shareowners.1. Brookfield Renewable PartnersWith climate change concerns mounting, the shift toward cleaner energy is set to be one of the most important and lucrative trends of the coming decade. Brookfield Renewable Partners (BEP) is exceptionally well-positioned to profit from this global megatrend.Brookfield Renewable is built to help the world achieve its energy transition and decarbonization goals. It owns a diverse collection of high-quality assets spanning wind, solar, hydroelectric, and other sustainable power projects. Its businesses are also geographically diversified, with operations across five continents. The limited partnership is designed to pass its bountiful cash flow on to its investors via a steadily growing distribution, which currently yields over 4%.  With demand for clean energy assured, Brookfield Renewable believes its investment pipeline will enable it to grow its already hefty cash payout by 5% to 9% annually and deliver total returns to investors of 12% to 15% per year. 2. Eli LillyWith potential blockbuster drugs in three massive markets -- diabetes, obesity, and Alzheimer's -- Eli Lilly (LLY) has an unrivaled growth pipeline among the pharmaceutical giants. Moreover, health trends suggest that the need for safe and effective treatments for these medical conditions will continue to grow as more people are expected to suffer from these disorders in the decade ahead. Lilly's Mounjaro received Food and Drug Administration (FDA) approval in May 2022 as an injectable medicine for adults with type 2 diabetes, to be used along with diet and exercise to improve glycemic control.Better still, the drug (also known as tirzepatide) produced promising results in a phase 3 clinical trial for weight loss. Participants in the 72-week study lost as much as 34 pounds, with more than 80% of people achieving at least a 5% reduction in body weight. Tirzepatide has multibillion-dollar sales potential in an obesity drug market that could reach $200 billion in the coming decade, according to investment bank Barclays. Lilly has another potential blockbuster in donanemab. In a phase 3 trial, it slowed cognitive and functional decline in patients with early Alzheimer's disease by 35% compared to a placebo.  Donanemab also helped to clear brain plaque that is associated with the disease, which affects more than 6 million in the U.S. alone. Lilly's well-stocked drug portfolio should allow it to generate impressive sales and profit growth -- and, by extension, strong returns to shareholders -- in the years ahead.3. TeslaTesla (TSLA) is another exceptional business that's poised to benefit from multiple megatrends. The first, of course, is the shift from gasoline-powered cars and trucks to electric vehicles (EVs). As the industry leader, it stands to profit from the rapidly rising adoption of battery-powered vehicles more than any other company.Profitability is improving as it scales up its production. The automaker's high operating margins are enabling it to reduce the prices of its vehicles to boost sales. This should help Tesla progress toward its goal of producing 20 million EVs per year by 2030, up from less than 1.4 million in 2022. An intensifying focus on software could drive profit margins even higher in the coming years. Cathy Wood's Ark Investment Management believes advances in autonomous driving technology will create an $11 trillion market opportunity by the end of the decade. Tesla is investing aggressively in self-driving tech and is well-positioned to be a leader in this potentially enormous industry. It also stands to benefit from the automation trend. The company unveiled its humanoid robot concept, called Optimus, at its AI Day event in September. It intends to develop and eventually mass-produce an AI-powered robot that can take on \"dangerous, repetitive, and boring tasks,\" according to CEO Elon Musk.The project is a priority for Musk, who believes Optimus could become the most valuable portion of the business in time. With such intriguing growth opportunities in EVs, self-driving software, and robotics, Tesla gives its shareholders many ways to win.","news_type":1},"isVote":1,"tweetType":1,"viewCount":102,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9970629012,"gmtCreate":1684403489436,"gmtModify":1684403495136,"author":{"id":"4110356800596672","authorId":"4110356800596672","name":"Melbas","avatar":"https://community-static.tradeup.com/news/4e59f56cdf45369101c12b25d1af19af","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4110356800596672","idStr":"4110356800596672"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AULT\">$Ault Alliance, Inc.(AULT)$&nbsp;</a>Are they real??? 😳😳😳😳","listText":"<a href=\"https://ttm.financial/S/AULT\">$Ault Alliance, Inc.(AULT)$&nbsp;</a>Are they real??? 😳😳😳😳","text":"$Ault Alliance, Inc.(AULT)$ Are they real??? 😳😳😳😳","images":[{"img":"https://community-static.tradeup.com/news/f5d3477ea43ed215518ba1c4153c33a6","width":"1290","height":"2796"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9970629012","isVote":1,"tweetType":1,"viewCount":694,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9012488828,"gmtCreate":1649374433936,"gmtModify":1676534499780,"author":{"id":"4110356800596672","authorId":"4110356800596672","name":"Melbas","avatar":"https://community-static.tradeup.com/news/4e59f56cdf45369101c12b25d1af19af","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4110356800596672","idStr":"4110356800596672"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CLVR\">$Clever Leaves Holdings Inc.(CLVR)$</a>Uhhhh noo","listText":"<a href=\"https://ttm.financial/S/CLVR\">$Clever Leaves Holdings Inc.(CLVR)$</a>Uhhhh noo","text":"$Clever Leaves Holdings Inc.(CLVR)$Uhhhh noo","images":[{"img":"https://community-static.tradeup.com/news/ec50de6bb2a95d16c3912ff7bc2c2654","width":"1242","height":"2688"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9012488828","isVote":1,"tweetType":1,"viewCount":355,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9010700666,"gmtCreate":1648463426809,"gmtModify":1676534340795,"author":{"id":"4110356800596672","authorId":"4110356800596672","name":"Melbas","avatar":"https://community-static.tradeup.com/news/4e59f56cdf45369101c12b25d1af19af","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4110356800596672","idStr":"4110356800596672"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CLVR\">$Clever Leaves Holdings Inc.(CLVR)$</a>Keep or Sale???","listText":"<a href=\"https://ttm.financial/S/CLVR\">$Clever Leaves Holdings Inc.(CLVR)$</a>Keep or Sale???","text":"$Clever Leaves Holdings Inc.(CLVR)$Keep or Sale???","images":[{"img":"https://community-static.tradeup.com/news/e1d5f3ea1c947d9489b042b67f96f69d","width":"1242","height":"2688"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010700666","isVote":1,"tweetType":1,"viewCount":320,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9010657237,"gmtCreate":1648367183572,"gmtModify":1676534331886,"author":{"id":"4110356800596672","authorId":"4110356800596672","name":"Melbas","avatar":"https://community-static.tradeup.com/news/4e59f56cdf45369101c12b25d1af19af","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4110356800596672","idStr":"4110356800596672"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CLVR\">$Clever Leaves Holdings Inc.(CLVR)$</a>Up","listText":"<a href=\"https://ttm.financial/S/CLVR\">$Clever Leaves Holdings Inc.(CLVR)$</a>Up","text":"$Clever Leaves Holdings Inc.(CLVR)$Up","images":[{"img":"https://community-static.tradeup.com/news/249b260171be75dec327a3e2566b5495","width":"1242","height":"2688"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010657237","isVote":1,"tweetType":1,"viewCount":426,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9010982804,"gmtCreate":1648240381174,"gmtModify":1676534319959,"author":{"id":"4110356800596672","authorId":"4110356800596672","name":"Melbas","avatar":"https://community-static.tradeup.com/news/4e59f56cdf45369101c12b25d1af19af","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4110356800596672","idStr":"4110356800596672"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CLVR\">$Clever Leaves Holdings Inc.(CLVR)$</a>I know it 🤣","listText":"<a href=\"https://ttm.financial/S/CLVR\">$Clever Leaves Holdings Inc.(CLVR)$</a>I know it 🤣","text":"$Clever Leaves Holdings Inc.(CLVR)$I know it 🤣","images":[{"img":"https://community-static.tradeup.com/news/caa8df5bfd54a8442e5ff0b27fcce3bb","width":"1242","height":"2688"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010982804","isVote":1,"tweetType":1,"viewCount":593,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9037462590,"gmtCreate":1648167349082,"gmtModify":1676534311978,"author":{"id":"4110356800596672","authorId":"4110356800596672","name":"Melbas","avatar":"https://community-static.tradeup.com/news/4e59f56cdf45369101c12b25d1af19af","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4110356800596672","idStr":"4110356800596672"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>Yay happy","listText":"<a href=\"https://ttm.financial/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>Yay happy","text":"$Sundial Growers Inc.(SNDL)$Yay happy","images":[{"img":"https://community-static.tradeup.com/news/c23bd6b8f0676b1dc40743035b20b700","width":"1242","height":"2688"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9037462590","isVote":1,"tweetType":1,"viewCount":1076,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9035789902,"gmtCreate":1647683427465,"gmtModify":1676534258442,"author":{"id":"4110356800596672","authorId":"4110356800596672","name":"Melbas","avatar":"https://community-static.tradeup.com/news/4e59f56cdf45369101c12b25d1af19af","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4110356800596672","idStr":"4110356800596672"},"themes":[],"htmlText":"B b but yh by n but,1bwrd oac&nbsp; kc pMmm Hi go back","listText":"B b but yh by n but,1bwrd oac&nbsp; kc pMmm Hi go back","text":"B b but yh by n but,1bwrd oac kc pMmm Hi go back","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035789902","repostId":"697451986","repostType":1,"repost":{"id":697451986,"gmtCreate":1642550400000,"gmtModify":1676532603351,"author":{"id":"4091672389332440","authorId":"4091672389332440","name":"咏竹坊","avatar":"https://static.tigerbbs.com/4c260c957a61e92224b833009be0747f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091672389332440","idStr":"4091672389332440"},"themes":[],"title":"Securities Regulator Takes on VIEs. Now It Needs to Address DRs","htmlText":"Chinese companies often use the Variable Interest Entity (VIE) structure to conduct initial public offerings (IPOs) outside the People’s Republic of China (PRC) and avoid certain restrictions on foreign investment. Recently the China Securities Regulatory Commission (CSRC) and other regulatory agencies published draft rules for such overseas offerings, which if adopted will be beneficial for investors. However, additional measures are needed to protect investors from a number of harmful practices currently occurring. Of particular concern is the use of depositary receipts (DRs) to offer securities in non-PRC markets. While many foreign companies use DRs to list outside their local market, the practice is especially problematic for PRC companies utilizing the VIE structure. That’s because i","listText":"Chinese companies often use the Variable Interest Entity (VIE) structure to conduct initial public offerings (IPOs) outside the People’s Republic of China (PRC) and avoid certain restrictions on foreign investment. Recently the China Securities Regulatory Commission (CSRC) and other regulatory agencies published draft rules for such overseas offerings, which if adopted will be beneficial for investors. However, additional measures are needed to protect investors from a number of harmful practices currently occurring. Of particular concern is the use of depositary receipts (DRs) to offer securities in non-PRC markets. While many foreign companies use DRs to list outside their local market, the practice is especially problematic for PRC companies utilizing the VIE structure. That’s because i","text":"Chinese companies often use the Variable Interest Entity (VIE) structure to conduct initial public offerings (IPOs) outside the People’s Republic of China (PRC) and avoid certain restrictions on foreign investment. Recently the China Securities Regulatory Commission (CSRC) and other regulatory agencies published draft rules for such overseas offerings, which if adopted will be beneficial for investors. However, additional measures are needed to protect investors from a number of harmful practices currently occurring. Of particular concern is the use of depositary receipts (DRs) to offer securities in non-PRC markets. While many foreign companies use DRs to list outside their local market, the practice is especially problematic for PRC companies utilizing the VIE structure. That’s because i","images":[{"img":"https://static.tigerbbs.com/b363e66eaace480887a409a48a4dea6d","width":"-1","height":"-1"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/697451986","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":540,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9037462590,"gmtCreate":1648167349082,"gmtModify":1676534311978,"author":{"id":"4110356800596672","authorId":"4110356800596672","name":"Melbas","avatar":"https://community-static.tradeup.com/news/4e59f56cdf45369101c12b25d1af19af","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4110356800596672","idStr":"4110356800596672"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>Yay happy","listText":"<a href=\"https://ttm.financial/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>Yay happy","text":"$Sundial Growers Inc.(SNDL)$Yay happy","images":[{"img":"https://community-static.tradeup.com/news/c23bd6b8f0676b1dc40743035b20b700","width":"1242","height":"2688"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9037462590","isVote":1,"tweetType":1,"viewCount":1076,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9010657237,"gmtCreate":1648367183572,"gmtModify":1676534331886,"author":{"id":"4110356800596672","authorId":"4110356800596672","name":"Melbas","avatar":"https://community-static.tradeup.com/news/4e59f56cdf45369101c12b25d1af19af","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4110356800596672","idStr":"4110356800596672"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CLVR\">$Clever Leaves Holdings Inc.(CLVR)$</a>Up","listText":"<a href=\"https://ttm.financial/S/CLVR\">$Clever Leaves Holdings Inc.(CLVR)$</a>Up","text":"$Clever Leaves Holdings Inc.(CLVR)$Up","images":[{"img":"https://community-static.tradeup.com/news/249b260171be75dec327a3e2566b5495","width":"1242","height":"2688"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010657237","isVote":1,"tweetType":1,"viewCount":426,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9010982804,"gmtCreate":1648240381174,"gmtModify":1676534319959,"author":{"id":"4110356800596672","authorId":"4110356800596672","name":"Melbas","avatar":"https://community-static.tradeup.com/news/4e59f56cdf45369101c12b25d1af19af","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4110356800596672","idStr":"4110356800596672"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CLVR\">$Clever Leaves Holdings Inc.(CLVR)$</a>I know it 🤣","listText":"<a href=\"https://ttm.financial/S/CLVR\">$Clever Leaves Holdings Inc.(CLVR)$</a>I know it 🤣","text":"$Clever Leaves Holdings Inc.(CLVR)$I know it 🤣","images":[{"img":"https://community-static.tradeup.com/news/caa8df5bfd54a8442e5ff0b27fcce3bb","width":"1242","height":"2688"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010982804","isVote":1,"tweetType":1,"viewCount":593,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9970629012,"gmtCreate":1684403489436,"gmtModify":1684403495136,"author":{"id":"4110356800596672","authorId":"4110356800596672","name":"Melbas","avatar":"https://community-static.tradeup.com/news/4e59f56cdf45369101c12b25d1af19af","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4110356800596672","idStr":"4110356800596672"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AULT\">$Ault Alliance, Inc.(AULT)$&nbsp;</a>Are they real??? 😳😳😳😳","listText":"<a href=\"https://ttm.financial/S/AULT\">$Ault Alliance, Inc.(AULT)$&nbsp;</a>Are they real??? 😳😳😳😳","text":"$Ault Alliance, Inc.(AULT)$ Are they real??? 😳😳😳😳","images":[{"img":"https://community-static.tradeup.com/news/f5d3477ea43ed215518ba1c4153c33a6","width":"1290","height":"2796"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9970629012","isVote":1,"tweetType":1,"viewCount":694,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9010700666,"gmtCreate":1648463426809,"gmtModify":1676534340795,"author":{"id":"4110356800596672","authorId":"4110356800596672","name":"Melbas","avatar":"https://community-static.tradeup.com/news/4e59f56cdf45369101c12b25d1af19af","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4110356800596672","idStr":"4110356800596672"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CLVR\">$Clever Leaves Holdings Inc.(CLVR)$</a>Keep or Sale???","listText":"<a href=\"https://ttm.financial/S/CLVR\">$Clever Leaves Holdings Inc.(CLVR)$</a>Keep or Sale???","text":"$Clever Leaves Holdings Inc.(CLVR)$Keep or Sale???","images":[{"img":"https://community-static.tradeup.com/news/e1d5f3ea1c947d9489b042b67f96f69d","width":"1242","height":"2688"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010700666","isVote":1,"tweetType":1,"viewCount":320,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":188607563837472,"gmtCreate":1687072468129,"gmtModify":1687072472770,"author":{"id":"4110356800596672","authorId":"4110356800596672","name":"Melbas","avatar":"https://community-static.tradeup.com/news/4e59f56cdf45369101c12b25d1af19af","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4110356800596672","idStr":"4110356800596672"},"themes":[],"htmlText":"Gg yg. &nbsp;B. Ta.\\_[\\.[ B f C","listText":"Gg yg. &nbsp;B. Ta.\\_[\\.[ B f C","text":"Gg yg. B. Ta.\\_[\\.[ B f C","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/188607563837472","repostId":"2343196599","repostType":2,"repost":{"id":"2343196599","pubTimestamp":1687053533,"share":"https://ttm.financial/m/news/2343196599?lang=&edition=fundamental","pubTime":"2023-06-18 09:58","market":"us","language":"en","title":"3 Top Stocks to Buy and Hold for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2343196599","media":"Motley Fool","summary":"These stalwarts can form the foundation of your portfolio.","content":"<html><head></head><body><p>A decade is a long time. But it&#39;s not impossible to identify the companies best situated to grow their revenue and earnings at above-average rates over the next 10 years. It can be a worthwhile and highly profitable exercise, as the companies stand to deliver fortune-building gains.</p><p>Here are three outstanding businesses that just might fit the bill. All three are set to benefit from powerful trends in the coming decade and deliver handsome rewards to their shareowners.</p><h2>1. <a href=\"https://laohu8.com/S/BEP\">Brookfield Renewable Partners</a></h2><p>With climate change concerns mounting, the shift toward cleaner energy is set to be one of the most important and lucrative trends of the coming decade. <strong>Brookfield Renewable Partners</strong> (BEP) is exceptionally well-positioned to profit from this global megatrend.</p><p>Brookfield Renewable is built to help the world achieve its energy transition and decarbonization goals. It owns a diverse collection of high-quality assets spanning wind, solar, hydroelectric, and other sustainable power projects. Its businesses are also geographically diversified, with operations across five continents. </p><p>The limited partnership is designed to pass its bountiful cash flow on to its investors via a steadily growing distribution, which currently yields over 4%.  With demand for clean energy assured, Brookfield Renewable believes its investment pipeline will enable it to grow its already hefty cash payout by 5% to 9% annually and deliver total returns to investors of 12% to 15% per year. </p><h2>2. <a href=\"https://laohu8.com/S/LLY\">Eli Lilly</a></h2><p>With potential blockbuster drugs in three massive markets -- diabetes, obesity, and Alzheimer&#39;s -- <strong>Eli Lilly</strong> (LLY) has an unrivaled growth pipeline among the pharmaceutical giants. Moreover, health trends suggest that the need for safe and effective treatments for these medical conditions will continue to grow as more people are expected to suffer from these disorders in the decade ahead. </p><p>Lilly&#39;s Mounjaro received Food and Drug Administration (FDA) approval in May 2022 as an injectable medicine for adults with type 2 diabetes, to be used along with diet and exercise to improve glycemic control.</p><p>Better still, the drug (also known as tirzepatide) produced promising results in a phase 3 clinical trial for weight loss. Participants in the 72-week study lost as much as 34 pounds, with more than 80% of people achieving at least a 5% reduction in body weight. Tirzepatide has multibillion-dollar sales potential in an obesity drug market that could reach $200 billion in the coming decade, according to investment bank <strong>Barclays</strong>. </p><p>Lilly has another potential blockbuster in donanemab. In a phase 3 trial, it slowed cognitive and functional decline in patients with early Alzheimer&#39;s disease by 35% compared to a placebo.  Donanemab also helped to clear brain plaque that is associated with the disease, which affects more than 6 million in the U.S. alone. </p><p>Lilly&#39;s well-stocked drug portfolio should allow it to generate impressive sales and profit growth -- and, by extension, strong returns to shareholders -- in the years ahead.</p><h2>3. <a href=\"https://laohu8.com/S/TSLA\">Tesla</a></h2><p><strong>Tesla</strong> (TSLA) is another exceptional business that&#39;s poised to benefit from multiple megatrends. The first, of course, is the shift from gasoline-powered cars and trucks to electric vehicles (EVs). As the industry leader, it stands to profit from the rapidly rising adoption of battery-powered vehicles more than any other company.</p><p>Profitability is improving as it scales up its production. The automaker&#39;s high operating margins are enabling it to reduce the prices of its vehicles to boost sales. This should help Tesla progress toward its goal of producing 20 million EVs per year by 2030, up from less than 1.4 million in 2022. </p><p>An intensifying focus on software could drive profit margins even higher in the coming years. Cathy Wood&#39;s Ark Investment Management believes advances in autonomous driving technology will create an $11 trillion market opportunity by the end of the decade. Tesla is investing aggressively in self-driving tech and is well-positioned to be a leader in this potentially enormous industry. </p><p>It also stands to benefit from the automation trend. The company unveiled its humanoid robot concept, called Optimus, at its AI Day event in September. It intends to develop and eventually mass-produce an AI-powered robot that can take on &#34;dangerous, repetitive, and boring tasks,&#34; according to CEO Elon Musk.</p><p>The project is a priority for Musk, who believes Optimus could become the most valuable portion of the business in time. With such intriguing growth opportunities in EVs, self-driving software, and robotics, Tesla gives its shareholders many ways to win.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Top Stocks to Buy and Hold for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Top Stocks to Buy and Hold for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-06-18 09:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/06/16/3-top-stocks-to-buy-and-hold-for-the-next-decade/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A decade is a long time. But it's not impossible to identify the companies best situated to grow their revenue and earnings at above-average rates over the next 10 years. It can be a worthwhile and ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/06/16/3-top-stocks-to-buy-and-hold-for-the-next-decade/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LU0056508442.USD":"贝莱德世界科技基金A2","LU0719512351.SGD":"JPMorgan Funds - US Technology A (acc) SGD","BK4551":"寇图资本持仓","BK4574":"无人驾驶","IE00B1XK9C88.USD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A\" (USD) ACC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","BK4581":"高盛持仓","LU2249611893.SGD":"BNP PARIBAS ENERGY TRANSITION \"CRH\" (SGD) ACC","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","LU0234572021.USD":"高盛美国核心股票组合Acc","BK4099":"汽车制造商","BK4511":"特斯拉概念","LU2063271972.USD":"富兰克林创新领域基金","BK4548":"巴美列捷福持仓","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","IE00BWXC8680.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5\" (SGD) ACC","LU0823414478.USD":"法巴经典能源转换基金","LU0097036916.USD":"贝莱德美国增长A2 USD","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","LU2087621335.USD":"ALLSPRING GLOBAL FACTOR ENHANCED EQUITY \"A\" (USD) ACC","LU2326559502.SGD":"Natixis Loomis Sayles US Growth Equity P/A SGD-H","LU1852331112.SGD":"Blackrock World Technology Fund A2 SGD-H","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","LU1861215975.USD":"贝莱德新一代科技基金 A2","TSLA":"特斯拉","LU0316494557.USD":"FRANKLIN GLOBAL FUNDAMENTAL STRATEGIES \"A\" ACC","LU1861558580.USD":"日兴方舟颠覆性创新基金B","LU1548497426.USD":"安联环球人工智能AT Acc","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","BK4533":"AQR资本管理(全球第二大对冲基金)","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","BK4555":"新能源车","LU0348723411.USD":"ALLIANZ GLOBAL HI-TECH GROWTH \"A\" (USD) INC","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","BK4527":"明星科技股","LU1429558221.USD":"Natixis Loomis Sayles US Growth Equity RA USD","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU1839511570.USD":"WELLS FARGO GLOBAL FACTOR ENHANCED EQUITY \"I\" (USD) ACC","BK4550":"红杉资本持仓","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4588":"碎股","LU0053666078.USD":"摩根大通基金-美国股票A（离岸）美元","LU1435385759.SGD":"Natixis Loomis Sayles US Growth Equity RA SGD-H","LU0823411888.USD":"法巴消费创新基金 Cap","LU0082616367.USD":"摩根大通美国科技A（dist）"},"source_url":"https://www.fool.com/investing/2023/06/16/3-top-stocks-to-buy-and-hold-for-the-next-decade/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2343196599","content_text":"A decade is a long time. But it's not impossible to identify the companies best situated to grow their revenue and earnings at above-average rates over the next 10 years. It can be a worthwhile and highly profitable exercise, as the companies stand to deliver fortune-building gains.Here are three outstanding businesses that just might fit the bill. All three are set to benefit from powerful trends in the coming decade and deliver handsome rewards to their shareowners.1. Brookfield Renewable PartnersWith climate change concerns mounting, the shift toward cleaner energy is set to be one of the most important and lucrative trends of the coming decade. Brookfield Renewable Partners (BEP) is exceptionally well-positioned to profit from this global megatrend.Brookfield Renewable is built to help the world achieve its energy transition and decarbonization goals. It owns a diverse collection of high-quality assets spanning wind, solar, hydroelectric, and other sustainable power projects. Its businesses are also geographically diversified, with operations across five continents. The limited partnership is designed to pass its bountiful cash flow on to its investors via a steadily growing distribution, which currently yields over 4%.  With demand for clean energy assured, Brookfield Renewable believes its investment pipeline will enable it to grow its already hefty cash payout by 5% to 9% annually and deliver total returns to investors of 12% to 15% per year. 2. Eli LillyWith potential blockbuster drugs in three massive markets -- diabetes, obesity, and Alzheimer's -- Eli Lilly (LLY) has an unrivaled growth pipeline among the pharmaceutical giants. Moreover, health trends suggest that the need for safe and effective treatments for these medical conditions will continue to grow as more people are expected to suffer from these disorders in the decade ahead. Lilly's Mounjaro received Food and Drug Administration (FDA) approval in May 2022 as an injectable medicine for adults with type 2 diabetes, to be used along with diet and exercise to improve glycemic control.Better still, the drug (also known as tirzepatide) produced promising results in a phase 3 clinical trial for weight loss. Participants in the 72-week study lost as much as 34 pounds, with more than 80% of people achieving at least a 5% reduction in body weight. Tirzepatide has multibillion-dollar sales potential in an obesity drug market that could reach $200 billion in the coming decade, according to investment bank Barclays. Lilly has another potential blockbuster in donanemab. In a phase 3 trial, it slowed cognitive and functional decline in patients with early Alzheimer's disease by 35% compared to a placebo.  Donanemab also helped to clear brain plaque that is associated with the disease, which affects more than 6 million in the U.S. alone. Lilly's well-stocked drug portfolio should allow it to generate impressive sales and profit growth -- and, by extension, strong returns to shareholders -- in the years ahead.3. TeslaTesla (TSLA) is another exceptional business that's poised to benefit from multiple megatrends. The first, of course, is the shift from gasoline-powered cars and trucks to electric vehicles (EVs). As the industry leader, it stands to profit from the rapidly rising adoption of battery-powered vehicles more than any other company.Profitability is improving as it scales up its production. The automaker's high operating margins are enabling it to reduce the prices of its vehicles to boost sales. This should help Tesla progress toward its goal of producing 20 million EVs per year by 2030, up from less than 1.4 million in 2022. An intensifying focus on software could drive profit margins even higher in the coming years. Cathy Wood's Ark Investment Management believes advances in autonomous driving technology will create an $11 trillion market opportunity by the end of the decade. Tesla is investing aggressively in self-driving tech and is well-positioned to be a leader in this potentially enormous industry. It also stands to benefit from the automation trend. The company unveiled its humanoid robot concept, called Optimus, at its AI Day event in September. It intends to develop and eventually mass-produce an AI-powered robot that can take on \"dangerous, repetitive, and boring tasks,\" according to CEO Elon Musk.The project is a priority for Musk, who believes Optimus could become the most valuable portion of the business in time. With such intriguing growth opportunities in EVs, self-driving software, and robotics, Tesla gives its shareholders many ways to win.","news_type":1},"isVote":1,"tweetType":1,"viewCount":102,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9012488828,"gmtCreate":1649374433936,"gmtModify":1676534499780,"author":{"id":"4110356800596672","authorId":"4110356800596672","name":"Melbas","avatar":"https://community-static.tradeup.com/news/4e59f56cdf45369101c12b25d1af19af","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4110356800596672","idStr":"4110356800596672"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CLVR\">$Clever Leaves Holdings Inc.(CLVR)$</a>Uhhhh noo","listText":"<a href=\"https://ttm.financial/S/CLVR\">$Clever Leaves Holdings Inc.(CLVR)$</a>Uhhhh noo","text":"$Clever Leaves Holdings Inc.(CLVR)$Uhhhh noo","images":[{"img":"https://community-static.tradeup.com/news/ec50de6bb2a95d16c3912ff7bc2c2654","width":"1242","height":"2688"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9012488828","isVote":1,"tweetType":1,"viewCount":355,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9035789902,"gmtCreate":1647683427465,"gmtModify":1676534258442,"author":{"id":"4110356800596672","authorId":"4110356800596672","name":"Melbas","avatar":"https://community-static.tradeup.com/news/4e59f56cdf45369101c12b25d1af19af","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4110356800596672","idStr":"4110356800596672"},"themes":[],"htmlText":"B b but yh by n but,1bwrd oac&nbsp; kc pMmm Hi go back","listText":"B b but yh by n but,1bwrd oac&nbsp; kc pMmm Hi go back","text":"B b but yh by n but,1bwrd oac kc pMmm Hi go back","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035789902","repostId":"697451986","repostType":1,"repost":{"id":697451986,"gmtCreate":1642550400000,"gmtModify":1676532603351,"author":{"id":"4091672389332440","authorId":"4091672389332440","name":"咏竹坊","avatar":"https://static.tigerbbs.com/4c260c957a61e92224b833009be0747f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091672389332440","idStr":"4091672389332440"},"themes":[],"title":"Securities Regulator Takes on VIEs. Now It Needs to Address DRs","htmlText":"Chinese companies often use the Variable Interest Entity (VIE) structure to conduct initial public offerings (IPOs) outside the People’s Republic of China (PRC) and avoid certain restrictions on foreign investment. Recently the China Securities Regulatory Commission (CSRC) and other regulatory agencies published draft rules for such overseas offerings, which if adopted will be beneficial for investors. However, additional measures are needed to protect investors from a number of harmful practices currently occurring. Of particular concern is the use of depositary receipts (DRs) to offer securities in non-PRC markets. While many foreign companies use DRs to list outside their local market, the practice is especially problematic for PRC companies utilizing the VIE structure. That’s because i","listText":"Chinese companies often use the Variable Interest Entity (VIE) structure to conduct initial public offerings (IPOs) outside the People’s Republic of China (PRC) and avoid certain restrictions on foreign investment. Recently the China Securities Regulatory Commission (CSRC) and other regulatory agencies published draft rules for such overseas offerings, which if adopted will be beneficial for investors. However, additional measures are needed to protect investors from a number of harmful practices currently occurring. Of particular concern is the use of depositary receipts (DRs) to offer securities in non-PRC markets. While many foreign companies use DRs to list outside their local market, the practice is especially problematic for PRC companies utilizing the VIE structure. That’s because i","text":"Chinese companies often use the Variable Interest Entity (VIE) structure to conduct initial public offerings (IPOs) outside the People’s Republic of China (PRC) and avoid certain restrictions on foreign investment. Recently the China Securities Regulatory Commission (CSRC) and other regulatory agencies published draft rules for such overseas offerings, which if adopted will be beneficial for investors. However, additional measures are needed to protect investors from a number of harmful practices currently occurring. Of particular concern is the use of depositary receipts (DRs) to offer securities in non-PRC markets. While many foreign companies use DRs to list outside their local market, the practice is especially problematic for PRC companies utilizing the VIE structure. That’s because i","images":[{"img":"https://static.tigerbbs.com/b363e66eaace480887a409a48a4dea6d","width":"-1","height":"-1"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/697451986","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":540,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}